Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Dis Esophagus

Retrieve available abstracts of 169 articles:
HTML format
Text format



Single Articles


    October 2018
  1. ZHANG YH, Herlin G, Rouvelas I, Nilsson M, et al
    Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response.
    Dis Esophagus. 2018 Oct 8. pii: 5123416. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. ZHANG R, Jia M, Li P, Han J, et al
    Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database.
    Dis Esophagus. 2018 Oct 1. pii: 5114250. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  3. CHEN YH, Yeh CJ, Wen YW, Chuang WY, et al
    Do dysplastic proximal resection margins predict the risk of anastomotic recurrence and overall survival in patients with esophageal squamous cell carcinoma?
    Dis Esophagus. 2018 Sep 17. pii: 5098583. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. GOENSE L, Meziani J, Bulbul M, Braithwaite SA, et al
    Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.
    Dis Esophagus. 2018 Sep 17. pii: 5098586. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  5. RUBENSTEIN JH, Morgenstern H, Longstreth K
    Clustering of esophageal cancer among white men in the United States.
    Dis Esophagus. 2018 Aug 30. pii: 5087691. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. OHKURA Y, Ueno M, Shindoh J, Iizuka T, et al
    Randomized controlled trial on efficacy of oligomeric formula (HINE E-GEL(R)) versus polymeric formula (MEIN(R)) enteral nutrition after esophagectomy for esophageal cancer with gastric tube reconstruction.
    Dis Esophagus. 2018 Aug 29. pii: 5086657. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. TIAN D, Zhang L, Wang Y, Chen L, et al
    Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.
    Dis Esophagus. 2018 Aug 27. pii: 5084843. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. GRAHAM-WISENER L, Collins L, Hanna J, Dempster M, et al
    The need for enhanced psychological support in esophageal cancer-an exploratory study of the perception of HCPs, patients, and carers.
    Dis Esophagus. 2018 Aug 16. pii: 5075410. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. KONNO-KUMAGAI T, Fujishima F, Nakamura Y, Nakano T, et al
    Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients.
    Dis Esophagus. 2018 Aug 6. pii: 5066745. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. YUEN MTY, Tsang RK, Wong IYH, Chan DKK, et al
    Long-term pharyngeal dysphagia after esophagectomy for esophageal cancer-an investigation using videofluoroscopic swallow studies.
    Dis Esophagus. 2018 Aug 2. pii: 5063837. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. CHEN SB, Huang SJ, Liu DT, Weng HR, et al
    Clinicopathological features and prognosis of esophageal squamous cell carcinoma in young patients.
    Dis Esophagus. 2018 Aug 1. pii: 5063602. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. SUNDE B, Johnsen G, Jacobsen AB, Glenjen NI, et al
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial.
    Dis Esophagus. 2018 Aug 1. pii: 5063601. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  13. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
    Dis Esophagus. 2018 Jul 23. pii: 5057168. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. CHENG B, Yu J
    Predictive value of diffusion-weighted MR imaging in early response to chemoradiotherapy of esophageal cancer: a meta-analysis.
    Dis Esophagus. 2018 Jul 16. pii: 5054272. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. AADAM AA, Abe S
    Endoscopic submucosal dissection for superficial esophageal cancer.
    Dis Esophagus. 2018 Jul 5. pii: 5049297. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  16. CHEN J, Lin Y, Cai W, Su T, et al
    A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy.
    Dis Esophagus. 2018 Jun 29. pii: 5046764. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. COSGROVE ND, Mullady DK
    Endoscopic evaluation of the esophageal cancer patient after chemoradiotherapy for persistent/recurrent cancer.
    Dis Esophagus. 2018 Jun 19. pii: 5040371. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. KROESE TE, Goense L, van Hillegersberg R, de Keizer B, et al
    Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Dis Esophagus. 2018 Jun 16. pii: 5039611. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. DOHERTY MK, Leung Y, Su J, Naik H, et al
    Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
    Dis Esophagus. 2018 Jun 14. pii: 5037798. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. SUN S, Chen P, Meng L, Li L, et al
    High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Dis Esophagus. 2018 Jun 14. pii: 5037792. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  21. CHEN MJ, Wu IC, Chen YJ, Wang TE, et al
    Nutrition therapy in esophageal cancer-Consensus statement of the Gastroenterological Society of Taiwan.
    Dis Esophagus. 2018 May 31. pii: 5025886. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. BOSHIER PR, Heneghan R, Markar SR, Baracos VE, et al
    Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2018 May 26. pii: 5006250. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. KUMAGAI Y, Tachikawa T, Higashi M, Sobajima J, et al
    Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
    Dis Esophagus. 2018 May 23. pii: 5001991. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. FELTRACCO P, Bortolato A, Barbieri S, Michieletto E, et al
    Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


    April 2018
  25. PARK SY, Kim DJ, Kang DR, Haam SJ, et al
    Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer.
    Dis Esophagus. 2018 Apr 13. pii: 4969978. doi: 10.1093.
    PubMed     Text format    


  26. MIZUMOTO T, Hiyama T, Oka S, Yorita N, et al
    Diagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection.
    Dis Esophagus. 2018;31.
    PubMed     Text format    


    March 2018
  27. SARVEPALLI S, Garg SK, Sarvepalli SS, Parikh MP, et al
    Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay.
    Dis Esophagus. 2018 Mar 28. pii: 4956135. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. MC CORMACK O, Mengardo V, Pucetti F, Chaudry A, et al
    Reply to letter: obesity and esophagectomy for esophageal cancer: is it only the high BMI that defines prognosis?
    Dis Esophagus. 2018 Mar 28. pii: 4956134. doi: 10.1093.
    PubMed     Text format    


  29. NAKAHARA Y, Yamasaki M, Miyazaki Y, Tanaka K, et al
    Reflux after esophagectomy with gastric conduit reconstruction in the posterior mediastinum for esophageal cancer: original questionnaire and EORTC QLQ-C30 survey.
    Dis Esophagus. 2018 Mar 28. pii: 4956131. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. DENG HY, Huang WX, Li G, Li SX, et al
    Comparison of short-term outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy in treating middle thoracic esophageal cancer.
    Dis Esophagus. 2018 Mar 9. pii: 4925701. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. TSILIMIGRAS DI, Schizas D, Moris D, Liakakos T, et al
    Obesity and esophagectomy for esophageal cancer: is it only the high BMI that defines prognosis?
    Dis Esophagus. 2018 Mar 7. pii: 4924676. doi: 10.1093.
    PubMed     Text format    


  32. HARADA K, Yoshida N, Baba Y, Nakamura K, et al
    Pyloroplasty may reduce weight loss 1 year after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


  33. MEGE D, Depypere L, Piessen G, Slaman AE, et al
    Surgical management of esophageal sarcoma: a multicenter European experience.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


  34. GADDAM S
    Prediction of Barrett's esophagus: are we there yet?
    Dis Esophagus. 2018;31.
    PubMed     Text format    


  35. ELSHAER M, Gravante G, Tang CB, Jayanthi NV, et al
    Totally minimally invasive two-stage esophagectomy with intrathoracic hand-sewn anastomosis: short-term clinical and oncological outcomes.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


  36. ORTIZ-FERNANDEZ-SORDO J, Sami SS, Mansilla-Vivar R, Subramanian V, et al
    Evaluation of a novel infra-red endoscopy system in the assessment of early neoplasia in Barretts esophagus: pilot study from a single center.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


  37. SUBRAMANIAM S, Kandiah K, Chedgy F, Meredith P, et al
    The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


  38. DAVIES AR, Zylstra J, Baker CR, Gossage JA, et al
    A comparison of the left thoracoabdominal and Ivor-Lewis esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


    February 2018
  39. KOSUMI K, Yoshida N, Okadome K, Eto T, et al
    Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer.
    Dis Esophagus. 2018 Feb 9. pii: 4850445. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. LEE J, Chin JH, Kim JI, Lee EH, et al
    Association between red blood cell transfusion and long-term mortality in patients with cancer of the esophagus after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


    January 2018
  41. FUJISHIMA F, Taniyama Y, Nakamura Y, Okamoto H, et al
    Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy.
    Dis Esophagus. 2018 Jan 13. pii: 4807355. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. WINIKER M, Mantziari S, Figueiredo SG, Demartines N, et al
    Accuracy of preoperative staging for a priori resectable esophageal cancer.
    Dis Esophagus. 2018;31:1-6.
    PubMed     Text format     Abstract available


  43. FUCHS HF, Schmidt HM, Meissner M, Brinkmann S, et al
    Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up.
    Dis Esophagus. 2018;31:1-6.
    PubMed     Text format     Abstract available


  44. BERKELMANS GHK, Fransen L, Weijs TJ, Lubbers M, et al
    The long-term effects of early oral feeding following minimal invasive esophagectomy.
    Dis Esophagus. 2018;31:1-8.
    PubMed     Text format     Abstract available


    December 2017
  45. MARKAR SR, Johar A, Maisey N, Lagergren P, et al
    Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
    Dis Esophagus. 2017 Dec 22. pii: 4774516. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. BUCKSTEIN M, Rhome R, Ru M, Moshier E, et al
    Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
    Dis Esophagus. 2017 Dec 22. pii: 4772688. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. MINAMI T, Yuasa N, Miyake H, Takeuchi E, et al
    MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Dec 19. pii: 4762060. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. LI HX, Liu J, Cheng Y, Liu MN, et al
    Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Dis Esophagus. 2017 Dec 19. pii: 4774512. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. MIZUMOTO T, Hiyama T, Oka S, Yorita N, et al
    Diagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection.
    Dis Esophagus. 2017 Dec 18. pii: 4757113. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. BOSHIER PR, Ziff C, Adam ME, Fehervari M, et al
    Effect of perioperative blood transfusion on the long-term survival of patients undergoing esophagectomy for esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Dec 18. pii: 4757112. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. KIM D, Min YW, Park JG, Lee H, et al
    Influence of esophagectomy on the gastroesophageal reflux in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  52. CHAO YK, Ku HY, Chen CY, Liu TW, et al
    Induction therapy before surgery improves survival in patients with clinical T3N0 esophageal cancer: a nationwide study in Taiwan.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  53. PARK SY, Kim DJ, Kang DR, Haam SJ, et al
    Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  54. KOSUMI K, Baba Y, Yamashita K, Ishimoto T, et al
    Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


    November 2017
  55. MAKINO T, Yamasaki M, Miyazaki Y, Wada N, et al
    Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017 Nov 28. pii: 4670862. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. VISSER E, van Rossum PSN, van Veer H, Al-Naimi K, et al
    A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.
    Dis Esophagus. 2017 Nov 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. KIKUCHI D, Iizuka T, Hoteya S, Nomura K, et al
    Vascular density of superficial esophageal squamous cell carcinoma determined by direct observation of resected specimen using narrow band imaging with magnifying endoscopy.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  58. MODI RM, Mikhail S, Ciombor K, Perry KA, et al
    Outcomes of nutritional interventions to treat dysphagia in esophageal cancer: a population-based study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  59. YAMASHITA K, Makino T, Yamasaki M, Tanaka K, et al
    Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  60. TSAI FC, Ghorbani S, Greenwald BD, Jang S, et al
    Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  61. TAKAHASHI K, Sato Y, Takeuchi M, Sato H, et al
    Changes in esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer: a high-resolution manometry study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  62. KOHLI DR, Schubert ML, Zfass AM, Shah TU, et al
    Performance characteristics of optical coherence tomography in assessment of Barrett's esophagus and esophageal cancer: systematic review.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  63. FUJIYOSHI T, Tajika M, Tanaka T, Ishihara M, et al
    Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  64. CORAL RP, Constant-Neto M, Silva IS, Barros S, et al
    The influence of the transposed stomach through the posterior mediastinum on the respiratory forced expiratory volume and forced vital capacity in patients with resected esophageal cancer.
    Dis Esophagus. 2017;11:48-50.
    PubMed     Text format     Abstract available


    October 2017
  65. AL NATOUR RH, Catanzaro A, Zolotarevsky E, DeBenedet AT, et al
    Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. TIE H, He F, Shen J, Zhang B, et al
    Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. SUN SY, Zhao BQ, Wang J, Mo ZX, et al
    The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. GRAHAM-WISENER L, Dempster M
    Peer advice giving from posttreatment to newly diagnosed esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  69. OH TK, Jeon JH, Lee JM, Kim MS, et al
    Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  70. BOHLE W, Kasper M, Zoller WG
    Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  71. CHEN CY, Hsieh VC, Chang CH, Chen PR, et al
    Impacts of treatments on the quality of life among esophageal squamous cell carcinoma patients.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  72. FUJIWARA H, Shiozaki A, Konishi H, Kosuga T, et al
    Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  73. DAI Z, Lang W, Yang H, Tian J, et al
    Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    September 2017
  74. LI QW, Qiu B, Wang B, Wang DL, et al
    Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. DEPYPERE L, Moons J, Lerut T, De Hertogh G, et al
    Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. OKAMURA A, Watanabe M, Mine S, Kurogochi T, et al
    Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  77. SHEN S, Araujo JL, Altorki NK, Sonett JR, et al
    Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  78. WELCH G, Ross HJ, Patel NP, Jaroszewski DE, et al
    Incidence of brain metastasis from esophageal cancer.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  79. TSANG JS, Tong DKH, Lam KO, Law BTT, et al
    Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  80. SONG T, Du D, Zhang X, Fang M, et al
    Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  81. MA Z, Chen C, Tang P, Zhang H, et al
    BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


    August 2017
  82. HUDDY JR, Huddy FMS, Markar SR, Tucker O, et al
    Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer - A narrative review.
    Dis Esophagus. 2017 Aug 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. YAP WK, Chang YC, Tseng CK, Hsieh CH, et al
    Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  84. NAKATANI M, Migita K, Matsumoto S, Wakatsuki K, et al
    Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  85. GANNON JA, Guinan EM, Doyle SL, Beddy P, et al
    Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer: a matched control study.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    July 2017
  86. SANFORD NN, Catalano PJ, Enzinger PC, King BL, et al
    A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  87. CHEN Y, Hao D, Wu X, Xing W, et al
    Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  88. HAISLEY KR, Hart KD, Nabavizadeh N, Bensch KG, et al
    Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    June 2017
  89. QIAN X, Tan C, Yang B, Wang F, et al
    Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  90. SUN L, Cao J, Guo C, Burnett J, et al
    Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  91. UNO K, Koike T, Kusaka G, Takahashi Y, et al
    Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  92. KAWAI R, Abe T, Uemura N, Fukaya M, et al
    Feeding catheter gastrostomy with the round ligament of the liver prevents mechanical bowel obstruction after esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  93. DOYLE SL, Mongan AM, Donohoe CL, Pidgeon GP, et al
    Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Text format     Abstract available


  94. MATSUEDA K, Manabe N, Toshikuni N, Sato Y, et al
    Clinical characteristics and associated factors of Japanese patients with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  95. LI SJ, Wang ZQ, Li YJ, Fan J, et al
    Diabetes mellitus and risk of anastomotic leakage after esophagectomy: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-12.
    PubMed     Text format     Abstract available


    May 2017
  96. HE Y, Liu J, Zhao Z, Zhao H, et al
    Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  97. CHEN HL, Shen WQ, Liu K
    Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-16.
    PubMed     Text format     Abstract available


  98. AKIYAMA Y, Iwaya T, Endo F, Shioi Y, et al
    Stability of cervical esophagogastrostomy via hand-sewn anastomosis after esophagectomy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  99. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor-Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  100. WIGHTMAN SC, Posner MC, Patti MG, Ganai S, et al
    Extremes of body mass index and postoperative complications after esophagectomy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    April 2017
  101. ZHANG Z, Zhang H
    Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  102. LACERDA CF, Cruvinel-Carloni A, de Oliveira AT, Scapulatempo-Neto C, et al
    Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  103. DE B, Rhome R, Doucette J, Buckstein M, et al
    Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  104. VAN RULER MA, Peters FP, Slingerland M, Fiocco M, et al
    Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  105. RATNASINGHAM K, Stroud L, Knight J, Preston SR, et al
    Analysis of 11 years of clinical negligence claims in esophagogastric cancer in England.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  106. DUAN J, Deng T, Ying G, Zhang H, et al
    Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  107. POWELL AG, Hughes DL, Brown J, Larsen M, et al
    Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  108. GIACOPUZZI S, Weindelmayer J, Treppiedi E, Bencivenga M, et al
    Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    March 2017
  109. MA M, Shroff S, Feldman M, DeMarshall M, et al
    Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  110. KOJIMA K, Yamashita K, Ushiku H, Katoh H, et al
    The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


    February 2017
  111. MARSHALL-WEBB M, Bright T, Price T, Thompson SK, et al
    Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  112. WEINER JP, Shao M, Schwartz D, Wong A, et al
    Patterns of care and survival outcomes in the treatment of esophageal melanoma.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  113. WONG AT, Shao M, Rineer J, Osborn V, et al
    Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  114. YANG H, Feng C, Cai BN, Yang J, et al
    Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  115. MURPHY CC, Yang YC, Shaheen NJ, Hofstetter WL, et al
    An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  116. MALIK V, Johnston C, O'Toole D, Lucey J, et al
    Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  117. ROSMOLEN WD, Nieuwkerk PT, Pouw RE, van Berge Henegouwen MI, et al
    Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  118. LINDNER K, Lubbe L, Muller AK, Palmes D, et al
    Potential risk factors and outcomes of fistulas between the upper intestinal tract and the airway following Ivor-Lewis esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  119. KJAER DW, Nassar M, Jensen LS, Svendsen LB, et al
    A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  120. MANNER H, Wetzka J, May A, Pauthner M, et al
    Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Text format     Abstract available


  121. CHEN H, Ni Z, Jing D, He L, et al
    Novel stent in the palliation of malignant esophageal strictures: a retrospective study.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  122. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    January 2017
  123. MATSUMOTO A, Watanabe M, Mine S, Nishida K, et al
    Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  124. LINDER G, Hedberg J, Bjorck M, Sundbom M, et al
    Perfusion of the gastric conduit during esophagectomy.
    Dis Esophagus. 2017;30:143-149.
    PubMed     Text format     Abstract available


  125. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  126. DEPYPERE L, Lerut T, Moons J, Coosemans W, et al
    Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  127. JANUSZEWICZ W, Kaminski MF, Wieszczy P, Wronska E, et al
    Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  128. GOENSE L, van Rossum PS, Tromp M, Joore HC, et al
    Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  129. SALEM AI, Thau MR, Strom TJ, Abbott AM, et al
    Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  130. WU HL, Guan BX, Liu B, Wang HJ, et al
    The intrapapillary capillary loop (IPCL) changes in superficial esophageal lesions.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  131. HAVERKAMP L, Seesing MF, Ruurda JP, Boone J, et al
    Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  132. PANTHAM G, Ganesan S, Einstadter D, Jin G, et al
    Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  133. ZHAO J, Han Y, Lei J, Zhou Y, et al
    Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  134. VAN ROSSUM PS, Haverkamp L, Carvello M, Ruurda JP, et al
    Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  135. VAN EGMOND MA, van der Schaaf M, Klinkenbijl JH, Engelbert RH, et al
    Preoperative functional status is not associated with postoperative surgical complications in low risk patients undergoing esophagectomy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  136. PARK A, Lee JH, Park A, Jung YH, et al
    Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  137. D'JOURNO XB, Berbis J, Jougon J, Brichon PY, et al
    External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  138. FUCHS HF, Harnsberger CR, Broderick RC, Chang DC, et al
    Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    November 2016
  139. NIE L, Wu HY, Shen YH, Fan XS, et al
    Esophageal submucosal gland duct adenoma: a clinicopathological and immunohistochemical study with a review of the literature.
    Dis Esophagus. 2016;29:1048-1053.
    PubMed     Text format     Abstract available


  140. ZHANG Z, Ai B, Liao Y, Liu L, et al
    Novel methylene blue staining technique for localizing small esophageal leiomyomas during thoracoscopic enucleation.
    Dis Esophagus. 2016;29:1043-1047.
    PubMed     Text format     Abstract available


  141. STIEKEMA J, Cats A, Boot H, Langers AM, et al
    Biobanking of fresh-frozen endoscopic biopsy specimens from esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:1100-1106.
    PubMed     Text format     Abstract available


  142. NOSHIRO H, Yoda Y, Hiraki M, Kono H, et al
    Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy.
    Dis Esophagus. 2016;29:1090-1099.
    PubMed     Text format     Abstract available


  143. ACAR T, Savas R, Kocacelebi K, Ersoz G, et al
    Squamous cell carcinoma arising from a Zenker's diverticulum: contribution of FDG-PET/CT to the diagnosis.
    Dis Esophagus. 2016;29:1170-1171.
    PubMed     Text format    


  144. SCARPA M, Cavallin F, Saadeh LM, Pinto E, et al
    Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status.
    Dis Esophagus. 2016;29:1064-1070.
    PubMed     Text format     Abstract available


  145. ZHAO X, Wang X, Li A, Sheng J, et al
    Endoscopic resection of a giant esophageal lipoma: a case report.
    Dis Esophagus. 2016;29:1167-1169.
    PubMed     Text format    


  146. NAGAI K, Tsujii Y, Matsui T, Yoshii S, et al
    Esophagogastric junctional adenocarcinoma originating from endoscopically unrecognizable Barrett's epithelium.
    Dis Esophagus. 2016;29:1164-1166.
    PubMed     Text format    


  147. RICE TW, Ishwaran H, Hofstetter WL, Kelsen DP, et al
    Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:897-905.
    PubMed     Text format     Abstract available


  148. RICE TW, Ishwaran H, Blackstone EH, Hofstetter WL, et al
    Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:913-919.
    PubMed     Text format     Abstract available


  149. RICE TW, Ishwaran H, Kelsen DP, Hofstetter WL, et al
    Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:906-912.
    PubMed     Text format     Abstract available


  150. SHAH IA, Bhat GA, Mehta P, Lone MM, et al
    Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
    Dis Esophagus. 2016;29:937-943.
    PubMed     Text format     Abstract available


  151. ZHAN C, Yan L, Wang L, Jiang W, et al
    Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Dis Esophagus. 2016;29:920-928.
    PubMed     Text format     Abstract available


    August 2016
  152. NIWA Y, Koike M, Fujimoto Y, Oya H, et al
    Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Dis Esophagus. 2016;29:598-602.
    PubMed     Text format     Abstract available


  153. KUNZLI HT, van Berge Henegouwen M, Gisbertz S, Seldenrijk C, et al
    Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study.
    Dis Esophagus. 2016;29:649-55.
    PubMed     Text format     Abstract available


  154. TSOU YK, Chuang WY, Liu CY, Ohata K, et al
    Learning curve for endoscopic submucosal dissection of esophageal neoplasms.
    Dis Esophagus. 2016;29:544-50.
    PubMed     Text format     Abstract available


  155. NABAVIZADEH N, Shukla R, Elliott DA, Mitin T, et al
    Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
    Dis Esophagus. 2016;29:614-20.
    PubMed     Text format     Abstract available


  156. BRANKLEY SM, Halling KC, Jenkins SM, Timmer MR, et al
    Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:513-9.
    PubMed     Text format     Abstract available


  157. OYA H, Kanda M, Koike M, Iwata N, et al
    Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2016;29:663-9.
    PubMed     Text format     Abstract available


  158. SWAGER A, Boerwinkel DF, de Bruin DM, Weusten BL, et al
    Volumetric laser endomicroscopy in Barrett's esophagus: a feasibility study on histological correlation.
    Dis Esophagus. 2016;29:505-12.
    PubMed     Text format     Abstract available


  159. CONG QX, Zhang H, Sun SX, Li HF, et al
    Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
    Dis Esophagus. 2016;29:621-6.
    PubMed     Text format     Abstract available


  160. MINEGAKI T, Fukushima S, Morioka C, Takanashi H, et al
    Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
    Dis Esophagus. 2016;29:656-62.
    PubMed     Text format     Abstract available


  161. SCARPA M, Filip B, Cavallin F, Alfieri R, et al
    Esophagectomy in elderly patients: which is the best prognostic score?
    Dis Esophagus. 2016;29:589-97.
    PubMed     Text format     Abstract available


  162. DAY RW, Jaroszewski D, Chang YH, Ross HJ, et al
    Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
    Dis Esophagus. 2016;29:583-8.
    PubMed     Text format     Abstract available


    July 2016
  163. HAVERKAMP L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, et al
    Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.
    Dis Esophagus. 2016;29:435-41.
    PubMed     Text format     Abstract available


  164. SUNDE B, Ericson J, Kumagai K, Lundell L, et al
    Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Dis Esophagus. 2016;29:442-7.
    PubMed     Text format     Abstract available


  165. WANG BJ, Zhang B, Yan SS, Li ZC, et al
    Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis.
    Dis Esophagus. 2016;29:448-54.
    PubMed     Text format     Abstract available


  166. MORI K, Yamagata Y, Aikou S, Nishida M, et al
    Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.
    Dis Esophagus. 2016;29:429-34.
    PubMed     Text format     Abstract available


  167. WAN J, Wu W, Che Y, Kang N, et al
    Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Dis Esophagus. 2016;29:412-20.
    PubMed     Text format     Abstract available


  168. LI B, Tang SP, Wang KZ
    Esophagus cancer and occupational exposure to asbestos: results from a meta-analysis of epidemiology studies.
    Dis Esophagus. 2016;29:421-8.
    PubMed     Text format     Abstract available


  169. JI WH, Jiang YH, Ji YL, Li B, et al
    Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Dis Esophagus. 2016;29:403-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: